COSA 2015* , ,
Presentations this author is a contributor to:
Precision medicine for advanced pancreas cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) trial (#268)
3:00 PM
Lorraine Chantrill
Posters1
The Lymphocyte-to-Monocyte ratio is a superior predictor of OS in comparison to established biomarkers in CRC patients undergoing curative resection. (#19)
11:15 AM
Joseph Chan
Best of the Best Orals - Clinical research
ALK Translocated Non-Small Cell Lung Cancer: Experience from an Australian metropolitan tertiary referral centre. (#367)
3:00 PM
Malinda Itchins
Posters 2